CATHERINE CLEVER: Open Payments
NPI 1134820855 · SAINT MARYS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 67 payments from 19 companies in 2025. Trend: 2023 $350 · 2024 $1,032 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $185 |
| Novo Nordisk Inc | 12 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $123 |
| Astellas Pharma US Inc | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Amgen Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $59 |
Products named: MOUNJARO, LEQVIO, Kerendia, Wegovy, Veozah, REXULTI, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
